04P-0506
CP 1
Volume 1

Citizen Petition

Tab 1 - Zacny, James et al. College on Problems of Drug Dependence task force on prescription opioid non-medical use and abuse: position statement. Drug and Alcohol Dependence 2003, 69, 215-232

Tab 2 - Butler SF, Budman SH, Katz N. Development and validation of a scale to measure attractiveness of prescription opioid products to potential opioid abusers. 2004

Tab 3 - The Pink Sheet. “OxyContin generics from Endo and Teva will include risk management plans.” Vol 66: page 28 (Mar. 29, 2004)

Tab 4 - Carter, Kathy A. Heat-Associated Increase in Transdermal Fentanyl Absorption. Am. J. Health-Syst. Pharm. 2003, 60, 191-192

Tab 5 - Newshan, PhD, ANP, Gayle. Heat-Related Toxicity with the Fentanyl Transdermal System, J. Pain Symptom Mgmt 1998, 16, 277-78